ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,015, issued on Sept. 22, was assigned to Ichnos Sciences SA (La Chaux-de-Fonds, Switzerland) and Astria Therapeutics Inc. (Boston).
"Affinity matured anti-OX40 antibodies and use thereof" was invented by Julie Macoin (La Chaux-de-Fonds, Switzerland), Thierry Monney (La Chaux-de-Fonds, Switzerland), Nikolaos Biris (Westborough, Mass.), Jill C. Milne (Boston), Christopher J. Morabito (Lexington, Mass.) and Chunxia Zhao (Boston).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are high affinity antagonistic anti-OX40 antibodies, methods of making such antibodies, and methods of using such antibodies to treat OX40-mediated disorders."
The...